4D Molecular Therapeutics Inc (FDMT)
$11.90 -6.89% Close Oct 30, 2026 Live
4D Molecular Therapeutics stock today
4D Molecular Therapeutics closed at $11.90 on October 30, 2026, down 6.89% on the day. Over the past year it returned +5.1% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $622 million.
$10.00$15.00
NovJan 2026MarMayJulSep
| Period | FDMT | S&P 500 (SPY) |
|---|---|---|
| 1 month | -16.8% | -0.9% |
| 3 months | +18.2% | +2.1% |
| Year to date | +58.7% | +11.7% |
| 1 year | +5.1% | +12.4% |
| 3 years | +11.9% | +88.5% |
| 5 years | -50.5% | +76.0% |
Key statistics
- Market value
- $622M
- Price / sales
- 6.8
- 52-week range
- $7.19 to $16.76
- Next report
- Nov 10, 2026 (estimated)
About 4D Molecular Therapeutics
Develops gene therapy treatments for inherited retinal diseases and other genetic disorders.
Sector: Health Care
More on 4D Molecular Therapeutics
- Financials: revenue, earnings and segmentsRevenue +230,195% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $495.21 today
No forecast, no recommendation. This page describes 4D Molecular Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.